infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 10 of 2,090 articles

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • Therapies

    Who will win the hepatitis C market?

    Seeking Alpha / 15 March 2011

  • Treatment issues

    FDA Panel To Review Merck, Vertex Hepatitis Drugs In Late April

    Wall Street Journal / 15 March 2011

  • Therapies

    The Hepatitis C Pipeline Report

    Treatment Action Group / 09 March 2011

  • Treatment issues

    Pharmasset Hep C Data Wows Investors

    The Street / 09 March 2011

  • New vaccine technology shows promise against hepatitis C virus

    Sify / 24 February 2011

  • Treatment issues

    Lack of health insurance limits hepatitis C patients' access to latest antiviral therapy

    Eurekalert Inf Dis / 24 February 2011

  • OraSure Technologies Receives FDA Approval for Its OraQuick(R) HCV Rapid Test Using Fingerstick Whole Blood

    Stock Markets Review / 22 February 2011

  • Treatment issues

    Medivir Announces Positive Phase 2b 48-week (SVR24) Interim Results of TMC435 in Treatment-Naive Patients Chronically Infected With Genotype-1 Hepatitis C Virus

    PR Newswire / 22 February 2011

  • Treatment issues

    Tibotec Starts Global Phase 3 Clinical Trials Studying TMC435 In Adults With Chronic Genotype 1 HCV

    Medical News Today / 22 February 2011

  • Nanotechnology may lead to new treatment of liver cancer

    Eurekalert Medicine & Health / 22 February 2011

← Prev1...205206207208209Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2022. All rights reserved. We are not responsible for the content of external websites.

Company limited by guarantee. Registered in England & Wales, number: 2707596. Registered charity, number: 1011220

Infohep has been supported by a grant from Gilead Sciences Europe Ltd. Our funder has had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

infohep is produced by NAM. Find out more about NAM

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//